European MPs back moves for generic drugs to be made available more quicklyBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f906 (Published 12 February 2013) Cite this as: BMJ 2013;346:f906
- Rory Watson
The European parliament has overwhelmingly backed moves to give patients faster access to generic drugs, saving money for them and for social security systems.
Under the proposal, adopted by 559 votes to 54 with 72 abstentions on 6 February, members of the parliament backed a 60 day deadline for decisions on the pricing and reimbursement of generic drugs. The current 180 day time limit would …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial